COMMUNIQUÉS West-GlobeNewswire

OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th
22/04/2026
BETHLEHEM, Pa., April 22, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2026 financial results and certain business [...]
Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria
22/04/2026
Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria Approval for children aged two to 11 years with CSU who remain [...]
Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
22/04/2026
STAFFORD, Texas, April 22, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is [...]
George Medicines: New England Journal of Medicine publishes global stroke outcomes trial that demonstrated reduction of risk for recurrent stroke by almost 40% with GMRx2 in patients with previous intracerebral hemorrhage
22/04/2026
Significant lowering of systolic blood pressure of 9mmHg on top of background treatment maintained with GMRx2 over an average follow-up of 3 years Safety findings similar to previous studies of GMRx2 London, UK, Boston [...]
SkinHealth Systems Inc. Appoints Three New Independent Directors to Board
22/04/2026
Kenneth Tripp, Dr. Sachin Shridharani, and E. Scott Beattie bring deep expertise in medical devices, aesthetic medicine, and global consumer brands LONG BEACH, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- SkinHealth [...]
Sight Sciences Announces the Release of its Sustainability Report
22/04/2026
The Sustainability Report provides data for 2023 through 2025 on the Company’s environmental, social, and governance initiatives MENLO PARK, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT [...]
Abivax to Present Data on Obefazimod at Digestive Disease Week®
22/04/2026
Abivax to Present Data on Obefazimod at Digestive Disease Week ® Presentations Highlight Comprehensive Efficacy, Safety, and Patient-Reported Outcomes from the Phase 3 ABTECT Program and Preclinical Anti-Fibrotic Models [...]
RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6
22/04/2026
ALISO VIEJO, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., today announced that it will report financial results for the first quarter after the market close on Wednesday, May 6, 2026. The [...]
Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
22/04/2026
HOUSTON, April 22, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous [...]
Communiqué de presse : Dupixent, développé par Sanofi et Regeneron, a été approuvé aux États-Unis comme étant le premier médicament biologique pour les jeunes enfants atteints d’urticaire chronique spontanée non contrôlée
22/04/2026
Dupixent, développé par Sanofi et Regeneron, a été approuvé aux États-Unis comme étant le premier médicament biologique pour les jeunes enfants atteints d’urticaire chronique spontanée non contrôlée Approbation pour les [...]
Supernus Pharmaceuticals to Announce First Quarter 2026 Financial Results and Host Conference Call on May 5, 2026
22/04/2026
ROCKVILLE, Md., April 22, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous [...]
Coloplast A/S - H1 2025/26 Earnings Release - Invitation for conference call on 12 May 2026 at 11:00 CEST
22/04/2026
Tuesday, 12 May 2026 at 11:00 - 12:00 CEST In connection with the publication of Coloplast’s interim financial results for H1 2025/26, to be released same day around 07:30 CEST, Coloplast will host a conference call to [...]
Mind Lab Pro Unveiled: Does This “Universal Nootropic” Really Improve Focus, Memory & Brain Power? Read Mind Lab PRO Report!
22/04/2026
Explore Mind Lab Pro’s science-backed formula, clinical insights & cognitive benefits. A complete guide to focus, memory & brain performance. New York City, NY, April 22, 2026 (GLOBE NEWSWIRE) -- In an era where [...]
EssilorLuxottica: Q1 2026 Revenue - Revenue rising 10.8% in Q1. Third consecutive quarter of double-digit growth
22/04/2026
Revenue rising 10.8% in Q1 Third consecutive quarter of double-digit growth Group revenue at Euro 7,127 million in Q1, up 10.8% at constant exchange rates 1 and +4.1% at current rates Both Professional Solutions and [...]
MedShop Direct Expands White Glove Delivery and Installation of Adjustable Medical Beds for Assisted Living and Home Care Across 48 States
22/04/2026
Houston, TEXAS, April 22, 2026 (GLOBE NEWSWIRE) -- MedShop Direct , an online supplier of assisted living and home care beds, announced today the expansion of its white-glove delivery and professional in-home [...]
Romeo Orthopaedics Welcomes Lauren Hennessy, MPAS, PA‑C, to Their Esteemed Team
22/04/2026
Lauren Hennessy Joins Romeo Orthopaedics to Support Specialized Care for Shoulder and Elbow Conditions Burr Ridge, ILLINOIS, April 22, 2026 (GLOBE NEWSWIRE) -- Romeo Orthopaedics, a leader in specialized care for [...]
Ipsen S.A. - Informations concernant la tenue de l’Assemblée Générale Mixte du 13 mai 2026
22/04/2026
Informations concernant la tenue de l’Assemblée Générale Mixte du 13 mai 2026 d’Ipsen S.A. Modalités de mise à disposition et de consultation des documents préparatoires à l’Assemblée PARIS, FRANCE, 22 AVRIL 2026 - [...]
EssilorLuxottica: Chiffre d'affaires T1 2026 - Chiffre d'affaires en hausse de +10,8 % au premier trimestre. Troisième trimestre consécutif de croissance à deux chiffres
22/04/2026
Chiffre d'affaires en hausse de +10,8 % au premier trimestre Troisième trimestre consécutif de croissance à deux chiffres Chiffre d'affaires du Groupe à 7 127 millions d'euros au T1, en hausse de +10,8 % à taux de [...]
Ipsen S.A. - Information relating to the holding of the Combined Shareholders’ Meeting of 13 May 2026
22/04/2026
Information relating to the holding of the Combined Shareholders’ Meeting of 13 May 2026 of Ipsen S.A. Formalities for making available and consulting preparatory documents to the Meeting PARIS, FRANCE, 22 APRIL 2026 - [...]

Pages